You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DYN Sale Disclosure
Kerr Douglas · SEC Form 4 · Filed Sep 8, 2026
Sale
Calculated transaction value
$24.36K
Kerr Douglas Chief Medical Officer
DYN
Transaction date
Sep 8, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed same day
DYN daily price context
Close on/before transaction
$20.31
Sep 8, 2026
First close after public filing
$19.19
Sep 9, 2026
30-day return after filing
-14.7%
Through Oct 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,290 shares @ $18.88
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001814189-26-000005
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$115.55K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dyne Therapeutics, Inc. DYN Current | Sale | Sep 8, 2026 | $24.36K |
| Dyne Therapeutics, Inc. DYN | Sale | Sep 4, 2026 | $91.19K |